Where Do The Presidential Candidates Stand On Science?

Next week, the country goes to the polls to pick a new president. In some respects the choices are clearcut. Under the relentless spotlight of the campaign trail, Michael Dukakis has emerged as a cool technocrat committed to such new social policies as universal health insurance and tighter cohtrols on military spending, while making no secret of his belief that current abortion law is correct. Bush, on the other hand, comes across as a friendly relative walking in the footsteps of Ronald Reagan

Written byJohn Carey
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Next week, the country goes to the polls to pick a new president. In some respects the choices are clearcut. Under the relentless spotlight of the campaign trail, Michael Dukakis has emerged as a cool technocrat committed to such new social policies as universal health insurance and tighter cohtrols on military spending, while making no secret of his belief that current abortion law is correct. Bush, on the other hand, comes across as a friendly relative walking in the footsteps of Ronald Reagan and advocating, among other things, a major cut in the capital gains tax and the “illegalization,” except in cases of rape, or abortion.

But when it comes to science and technology issues, both candidates are largely enigmas. Yet, during the next few years, a number of crucial decisions on science and technology will have to be made. Should the United States double the budget of the National ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies